Simultaneous separation of 11 protease and reverse transcriptase inhibitors for human immunodeficiency virus therapy by co-electroosmotic capillary zone electrophoresis

被引:14
作者
Gutleben, W
Scherer, K
Tuan, ND
Stoiber, H
Dierich, MP
Zemann, A
机构
[1] Univ Innsbruck, Inst Analyt Chem & Radiochem, A-6020 Innsbruck, Austria
[2] Univ Innsbruck, Inst Hyg & Social Med, A-6020 Innsbruck, Austria
关键词
human immunodeficiency virus; electroosmotic flow; enzyme inhibitors;
D O I
10.1016/S0021-9673(02)01430-9
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In the present investigation, a co-electroosmotic capillary zone electrophoretic method is shown for the simultaneous separation of protease inhibitors and reverse transcriptase inhibitors, which are used as antiretroviral therapy drugs against the human immunodeficiency virus (HIV). The investigated drugs carry basic amino groups, thus the electrophoretic system takes advantage of an acidic buffer electrolyte. In order to establish a strong cathodic electroosmotic flow (EOF), a poly-anionic surfactant is added to the background electrolyte. Thus, fast migration times due to a co-directional migration of analytes and EOF (co-electroosmotic CE) are obtained. The developed separation system exhibits good selectivities for the investigated compounds and sufficient sensitivity to monitor drug levels in the low ppm range in HIV positive patients who are treated by highly active anitiretroviral therapy. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:153 / 161
页数:9
相关论文
共 38 条
[1]   THE STRENGTH OF HETEROCYCLIC BASES [J].
ALBERT, A ;
GOLDACRE, R ;
PHILLIPS, J .
JOURNAL OF THE CHEMICAL SOCIETY, 1948, (DEC) :2240-2249
[2]  
[Anonymous], 1981, MMWR MORB MORTAL WKL, V30, P305
[3]   Determination at ppb level of an anti-human immunodeficiency virus nucleoside drug by capillary electrophoresis-electrospray ionization tandem mass spectrometry [J].
Cahours, X ;
Dessans, H ;
Morin, P ;
Dreux, M ;
Agrofoglio, L .
JOURNAL OF CHROMATOGRAPHY A, 2000, 895 (1-2) :101-109
[4]   Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease [J].
Cameron, DW ;
Heath-Chiozzi, M ;
Danner, S ;
Cohen, C ;
Kravcik, S ;
Maurath, C ;
Sun, E ;
Henry, D ;
Rode, R ;
Potthoff, A ;
Leonard, J .
LANCET, 1998, 351 (9102) :543-549
[5]  
Centers for Disease Control (CDC), 1982, MMWR Morb Mortal Wkly Rep, V31, P577
[6]   Determination of human immunodeficiency virus-1 protease inhibitors in patient serum using free solution capillary zone electrophoresis [J].
Chelyapov, N ;
Jacobs, SA ;
Magee, TJ .
JOURNAL OF CHROMATOGRAPHY A, 1999, 853 (1-2) :431-437
[7]  
CURRAN JW, 1982, NEW ENGL J MED, V306, P248
[8]   Rapid quantification of indinavir in human plasma by high-performance liquid chromatography with ultraviolet detection [J].
Foisy, ML ;
Sommadossi, JP .
JOURNAL OF CHROMATOGRAPHY B, 1999, 721 (02) :239-247
[9]   Simultaneous determination of ritonavir and saquinavir, two human immunodeficiency virus protease inhibitors, in human serum by high-performance liquid chromatography [J].
Frappier, S ;
Breilh, D ;
Diarte, E ;
Ba, B ;
Ducint, D ;
Pellegrin, JL ;
Saux, MC .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1998, 714 (02) :384-389
[10]  
*GLAX, 2001, MAT SAF DAT SHEET TR